Ads
related to: biotech and pharma
Search results
Ginkgo Bioworks Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 2 days agoCimino: Ginkgo Bioworks has built a cell engineering platform that's attracted a wide range of customers across industries. The company has seen the most...
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via Yahoo Finance· 4 days agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma...
CinRx Pharma portfolio company CinDome raises $40M toward Series B round - Cincinnati Business...
The Business Journals· 5 days agoThe raise was led by New York-based investment firm Perceptive Advisors and CinRx Pharma and brings...
No, strict environmental rules do not harm global high-tech firms competitiveness
The Conversation· 4 days agoOffhand, you may not think of the pharmaceutical and biotech industry as the greenest one around. The healthcare industry’s net emissions (nearly a third ...
Petri Dish: Compass CEO’s short tenure; Agios sells drug rights - Boston Business Journal
The Business Journals· 3 days agoThis week’s Petri Dish welcomes a new chief financial officer to bluebird bio. Meanwhile, Compass...
TD Cowen expects Medpace to 'outpace large pharma', initiates buy rating on stock By Investing.com
Investing.com· 4 days agoThe firm assigned a Buy rating to Medpace, accompanied by a price target of $452.00. The coverage...
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
InvestorPlace· 4 days agoNot long ago, GameStop (NYSE:GME) stock soared and then tanked on the meme-stock waves. A company...
FutureBridge set to engage with industry leaders at 2024 ASCO® Annual Meeting and BIO 2024...
Benzinga· 2 days agoFutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets, reimbursement and& ...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 4 days agoAmong Davis’s deals were the $10.8 billion purchase of the immune-drug developer Prometheus...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 6 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
